PHA-665752 Catalog No.:M7762-2 and pancreatic and breast cancers)

and pancreatic and breast cancers)

two of the most prominent Cdc42-mediated subcellular events

suggesting that the inhibitory activity is likely to be via a direct and fast mechanism

Epub 2009 Aug 3

InChiKey: DUPAJELXESPTNF-PPZGWQTASA-N

PHA-665752 Catalog No.:M7762-2 and pancreatic and breast cancers)PHA665752 is a potent and selective inhibitor of c Met HGF SF (IC50 values are 9, 68, 200, 1400, 3000, 3800 and 6000 nM for MET, Ron, Flk 1, c abl, FGFR1, EGFR and c src respectively). PHA 665752 suppresses the hepatocyte growth factor induced cell proliferation and radioresistance in nasopharyngeal carcinoma cells. PHA 665752 reverses lung premalignancy induced by mutant K ras. PHA 665752 induced apoptosis of a lung adenocarcinoma cell line derived